October 21, 2021

Among the available biomarkers for age-related macular degeneration (AMD) is delayed dark-adapted vision recovery. However, its use is burdensome for both patients and examiners. This study, published in Eye and Brain, sought to determine the utility of a novel portable system in measuring dark-adapted visual evoked potentials (DAVEP), a metric for delayed dark-adapted vision recovery. The...

With sickle cell disease (SCD) predominately affecting people of African descent, understanding how to improve SCD outcomes is crucial to rectifying health disparities.  The National Heart and Lung Association funded several centers to participate in the Sickle Cell Disease Implementation Consortium. This study, published in the Journal of Immigrant and Minority Health, analyzed these centers’ strategies...

Hematopoietic stem cell transplant (HSCT) remains the most effective way to cure sickle cell disease. However, its use is still limited by several challenges, including a lack of suitable donors, the risk of graft-versus-host disease, and therapy-related toxicity.  This study, published in Bone Marrow Transplantation, sought to determine the safety and efficacy of using donor-derived anti-3rd...

Due to the developing nature of the ongoing COVID-19 pandemic, the effect of other health conditions on COVID-19 outcomes is not yet clear. This study, published in Blood Advances, identified predictors of outcomes and survival in patients with COVID-19 and sickle cell disease.  Data from patients in four COVID-19 epicenters were used. Patients had a median...